Emma Biegacki, MPH
she/her/hers
Program Manager 2Cards
Additional Titles
Program Manager, Yale Program in Addiction Medicine
Contact Info
About
Titles
Program Manager 2
Program Manager, Yale Program in Addiction Medicine
Biography
Emma is a public health professional experienced in program and grants management, evaluation, and strategic planning. She is invested in improving wellbeing for people who use drugs and those with a substance use disorder, and in advancing the principles and strategies of harm reduction through community-led policy-and-practice reform.
Emma joined the Yale Program in Addiction Medicine in 2019. As Program Manager, she oversees day-to-day operations, communications, and organizational strategy spanning clinical practice, education, research, policy, and community engagement initiatives. She additionally coordinates the Collaborative Behavioral Health and Addiction Medicine in Primary Care (CHAMP) Program and the Substance Use Skills Training to Advance INtegrated Care (SUSTAIN) Program, and supports a wide array of special projects in collaboration with Yale Schools of Medicine and Public Health colleagues as well as local, state, and national partners.
Appointments
Departments & Organizations
Education & Training
- MPH
- University of Washington, Community-Oriented Public Health Practice (2019)
- BA
- University of Pennsylvania, Public Health (2015)
Research
Overview
Medical Research Interests
Addiction Medicine; Community-Based Participatory Research; Delivery of Health Care, Integrated; Harm Reduction; Health Communication; Health Services Accessibility; Hepatitis C, Chronic; HIV
Public Health Interests
Chronic Diseases; Community Health; Health Policy; Stigma and Discrimination; Substance Use, Addiction; Health Equity, Disparities, Social Determinants and Justice; Health Systems Reform
ORCID
0000-0003-0828-2869
Research at a Glance
Yale Co-Authors
Frequent collaborators of Emma Biegacki's published research.
Research Interests
Research topics Emma Biegacki is interested in exploring.
Benjamin Oldfield, MD, MHS, BA
David Fiellin, MD
Jeanette Tetrault, MD, FACP, FASAM
Kimberly Sue, MD, PhD
E. Jennifer Edelman, MD, MHS, BS
Katie Hill, MPH
Addiction Medicine
Health Services Accessibility
Publications
2024
Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study
Hill K, Minahan-Rowley R, Biegacki E, Heimer R, Sue K. Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study. Harm Reduction Journal 2024, 21: 148. PMID: 39148036, PMCID: PMC11328386, DOI: 10.1186/s12954-024-01052-4.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsSequential explanatory mixed-methods studyExplanatory mixed-methods studyMixed-methods studyHealthcare providersHealthcare providers' experiencesHealthcare providers treating patientsSample of providersProviders treating patientsDrug supplyProvider experienceProvider knowledgeIn-depth interviewsImprove careSense of helplessnessConvenience sampleHealthcare educationThematic analysisInterview transcriptsQualitative phasePurposive samplingProvidersHealthcareOpioid supplyAbsence of literatureResultsSeventy-eightDevelopment of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis.
Chan C, Minahan-Rowley R, Biegacki E, Sue K, Weimer M. Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis. Substance Use & Addiction Journal 2024, 29767342241267077. PMID: 39087514, DOI: 10.1177/29767342241267077.Peer-Reviewed Original ResearchAltmetricConceptsInjection drug use-related infective endocarditisSemi-structured interviewsInjection drug usePatient participationPatient websitesInjection practicesInfective endocarditisPatient education resourcesHelpfulness of informationHistory of injection drug useDrug useMixed-methods studyHealthcare cliniciansBaseline surveyOpioid use disorderPrevention strategiesInformation websitesEducational materialsCounseling patientsHospitalized adultsPromote educationWebsite sectionsCliniciansSurvey feedbackUse disorderHepatitis C virus and integrated care for substance use disorders
Mahoney B, Morford K, Biegacki E, Tetrault J. Hepatitis C virus and integrated care for substance use disorders. Clinical Liver Disease 2024, 23: e0241. PMID: 38952692, PMCID: PMC11216679, DOI: 10.1097/cld.0000000000000241.Peer-Reviewed Original ResearchCOVID-19 and the American Overdose Crisis
Biegacki ET, Morford KL, Heimer R. COVID-19 and the American Overdose Crisis. In: COVID-19 and Public Health: Global Responses to the Pandemic. Ohio University Press; 2024:245-282.Chapters
2023
Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study
Strong S, Oldfield B, van den Berg J, Cole C, Biegacki E, Ogbuagu O, Virata M, Chan P, Edelman E. Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study. Preventive Medicine Reports 2023, 37: 102553. PMID: 38282665, PMCID: PMC10810836, DOI: 10.1016/j.pmedr.2023.102553.Peer-Reviewed Original ResearchCitationsConceptsUnhealthy alcohol usePre-exposure prophylaxisAlcohol reduction interventionsAlcohol useHIV pre-exposure prophylaxisOral pre-exposure prophylaxisAcquisition of HIVAlcohol-related harmPrEP adherencePrEP careTreatment optionsOral formulationReduction interventionsPrEP programMSMPrEPProphylaxisHIVMultimodal approachMenCareAdherenceInterventionSexUnited StatesAssociations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys
Chen K, Oldfield B, Joudrey P, Biegacki E, Fiellin D. Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys. Journal Of Addiction Medicine 2023, 17: 544-550. PMID: 37788607, DOI: 10.1097/adm.0000000000001174.Peer-Reviewed Original ResearchDrive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States
Joudrey P, Chen K, Oldfield B, Biegacki E, Fiellin D. Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States. Journal Of Addiction Medicine 2023, 17: 615-617. PMID: 37788621, PMCID: PMC10591456, DOI: 10.1097/adm.0000000000001170.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsMedian drive timeCM providersContingency managementMOUD servicesUrban census tractsOpioid use disorder servicesRural-Urban Commuting Area codesQualified health centersCensus tractsAddiction treatment facilitiesDisorder treatment providersDrive timeMOUD treatmentHealth centersOutpatient substanceDisorder servicesFacility surveyUrban-rural disparitiesTractTreatment providersFQHCsArea codesMinutesUS statesProvidersAvailability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey.
Oldfield BJ, Chen K, Joudrey PJ, Biegacki ET, Fiellin DA. Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey. J Addict Med 2023 PMID: 36930235, DOI: 10.1097/ADM.0000000000001158.Peer-Reviewed Original Research
2022
Emergency Response Systems Must Not Overlook People with Substance Use Disorders
Biegacki, Emma T. Emergency Response Systems Must Not Overlook People with Substance Use Disorders. STAT News. March 2022.Publications for non-academic audiencesCommentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine
Biegacki ET, Tetrault JM, Fiellin DA. Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine. Substance Abuse 2022, 43: 1215-1220. PMID: 35657646, DOI: 10.1080/08897077.2022.2074606.Commentaries, Editorials and LettersAltmetric
News & Links
News
- May 27, 2024
Unhealthy Alcohol Use Among Men who have Sex with Men Taking PrEP for HIV Prevention
- April 30, 2024
Amid Opioid Overdose Crisis, Yale Program in Addiction Medicine Advises State on Drug Company Settlement Spending
- January 23, 2024
Yale Emergency Physicians Pioneer Transformative Data-to-Action Infrastructure Powering Evidence-Based Care for Opioid Use Disorder
- October 06, 2023
Addiction Medicine Fellowship Training at Yale Expands To Advanced Practice Providers
Get In Touch
Contacts
Locations
Program in Addiction Medicine
Academic Office
E.S. Harkness Memorial Hall, Building A
367 Cedar Street, Fl 4
New Haven, CT 06510
Events
Dec 202417Tuesday
Everyone Sharon Ostfeld-Johns, MD, IBCLCThis session will be held virtually via Zoom. Registration link forthcoming.
Feb 202511Tuesday
Everyone Hansel Tookes, MD, MPHThis session will be held virtually via Zoom. Registration link forthcoming.
Mar 202511Tuesday
Everyone Sara N Edmond, PhDThis session will be held virtually via Zoom. Registration link forthcoming.
Mar 202525Tuesday
Everyone Gideon Lasco, MD, PhDThis session will be held virtually via Zoom. Registration link forthcoming.